ArticleWorld journal of urology2023

Conservative treatment for high-risk NMIBC failing BCG treatment: who benefits from adding electromotive drug administration (EMDA) of mitomycin C (MMC) to a second BCG induction cycle?

Gian Maria Busetto et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.